杂志简称：indian j hematol blo
中文译名：《印度血液学与输血杂志》
收录属性：scie（2024版）, 目次收录（维普）,英文期刊,
投稿方向：医学、hematology 血液学
SCI/E期刊基本信息
出版周期：季刊 地区：印度
中科院分区：4区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN0971-4502；EISSN0974-0449
杂志语言：英语
出版国家：印度
杂志官网 联系方式
出版地址：7TH FLOOR,VIJAYA BUILDING,17,BARAKHAMBA ROAD,NEW DELHI,INDIA,110 001
杂志邮箱：
投稿网址：https://www.editorialmanager.com/ijhb/
杂志官方网址：https://www.springer.com/journal/12288
出版商网址：http://www.springerlink.com/
杂志投稿要求
期刊相关咨询邮箱【杂志社官方网站信息】
Contact the journal
Submission-related enquiries
Queries about submission issues, peer review process, or the status of your manuscript should be sent to Aishwarya Kamalakannan (Aishwarya.Kamalakannan@springernature.com).
Production-related enquiries
Queries about accepted manuscripts in production or post-publication corrections should be sent to Suganya Maharajan (Suganya.Maharajan@Springer.com).
Rights and Permissions enquiries
For permission requests to reuse or reprint content, please follow the link ‘Rights and permissions’ on the relevant article page. For other queries, contact journalpermissions@springernature.com.
Publication-related enquiries
Queries related to journal publishing should be sent to Eti Dinesh (Eti.Dinesh@springer.com).
投稿须知【杂志社官方网站信息】
Indian Journal of Hematology and Blood Transfusion
Submission guidelines
Instructions for authors
Types of papers
OverviewReview Article [by invitation only]:Word limit 3500 words (excluding the abstract, tables, figure legends and references), with up to 8 tables/figures and up to 100 references.Always invited by the Editor-in-Chief; authors interested in writing review articles should initially contact the Editor-in-Chief. Review Articles focus on recent scientific or advances in areas of interest to clinical and laboratory hematologists. They must be concise and critical yet comprehensive and should be appropriately referenced. All Review Articles are rigorously peer reviewed before a final publication decision is made. Involvement of any person or research directly supported by the pharmaceutical industry is not acceptable in writing of Review Articles.
Original Articles [formerly known as Original Research]: Word limit 2500 words (excluding the abstract, tables, figure legends and references), with up to 5 tables/figures and up to 50 references. Organize article into a structured Abstract (maximum 250 words), Introduction, Materials and Methods, Results, Discussion, References, Tables, Legends to Figures, Figures. Acknowledgements should go into the separate Title Page file.
Short Research Communication [includes the former categories of Brief Original Research and Technical note]:Word limit 1200 words (excluding the structured 200 word abstract, tables, figure legends and references), with up to 3 tables/figures and up to 20 references. Research findings too brief/preliminary to be published as original articles. Please note individual case reports cannot be submitted in this section. Case series may however be submitted, especially those describing novel approaches to therapy or presenting new information. Sections should be organized as for Original Research.
Images in Hematology:Word limit 200 words (excluding the abstract, tables, figure legends and references), with up to 2 tables/figures with up to 2 references.Images displaying a single clinical / pathological case or entity and conveying a message or learning point can be published as image in hematology. Up to 2 microscopic images, clinical photographs, radiological images, graphical/visual instrument outputs etc. may be included in each article. Images should be accompanied by a brief unstructured write-up. No abstract is required.
My Approach to Treatment/Diagnosis [by invitation only]: Word limit 3000 words (excluding the abstract, tables, figure legends and references), with up to 6 tables/figures and up to 50 references.These are usually invited by the Editor-in-Chief. Authors interested in writing unsolicited articles in this category should first contact the Editor-in-Chief. Articles written by experts illustrating up-to-date clinical, management or diagnostic approaches to hematological entities or situations. Preferably, “My approach to Treatment/Diagnosis” articles are single-authored, and should open with an educative or typical clinical case. Articles having more than one author must be explicitly pre-approved by the Editor-in-Chief before submission. The article should include an abstract of up to 250 words. Article structure can be varied. Involvement of any person or research directly supported by the pharmaceutical industry is not acceptable in writing of “My approach to Treatment/Diagnosis” articles.
Research Letter / Correspondence:Word limit 600 words with up to 1 figure and up to 5 references.Brief letters either commenting on published articles in the journal, presenting brief data or describing interesting cases can be submitted. Correspondence submissions should begin with “Dear Editor” and are subjected to the usual peer-review process. No abstract is required.
Editorial:Word limit 750 words with up to 5 references. Invited by the Editor-in-Chief, these are brief commentaries on important original articles published in that issue of the journal. Occasionally, Editorials may address major developments or happenings in the field of hematology. Figures and tables are usually not included in this article type.
Manuscript Submission
Manuscript Submission
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Permissions
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Online Submission
Please follow the hyperlink “Submit manuscript” on the right and upload all of your manuscript files following the instructions given on the screen.
Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.